PROCEPT BioRobotics Corp (PRCT) stock
PRCTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/3051% below fair value
$23.51+0.17 (+0.73%)
Close on Nov 12, 2026Market cap $1.35BP/E –Yield –
PROCEPT BioRobotics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
PROCEPT BioRobotics's enterprise value was $1.16B on Nov 11, 2026, against $1.53B a year earlier. Over the last 5 years it ranged from $535.25M to $4.84B, with a median of $1.54B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.16B | -23.4% |
| 2025 | Dec 31, 2025 | $1.51B | -62.6% |
| 2024 | Dec 31, 2024 | $4.05B | +115.7% |
| 2023 | Dec 29, 2023 | $1.88B | +13.3% |
| 2022 | Dec 30, 2022 | $1.66B | +103.2% |
| 2021 | Dec 31, 2021 | $816.51M | – |
See a number that looks wrong?